ReviewVaccines2024

Feasibility of Using a Type I IFN-Based Non-Animal Approach to Predict Vaccine Efficacy and Safety Profiles.

Hanin Abdel-HaqPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.